000182535 001__ 182535
000182535 005__ 20240229145721.0
000182535 0247_ $$2doi$$a10.1016/j.lungcan.2022.10.011
000182535 0247_ $$2pmid$$apmid:36356492
000182535 0247_ $$2ISSN$$a0169-5002
000182535 0247_ $$2ISSN$$a1872-8332
000182535 0247_ $$2altmetric$$aaltmetric:140222414
000182535 037__ $$aDKFZ-2022-02727
000182535 041__ $$aEnglish
000182535 082__ $$a610
000182535 1001_ $$0P:(DE-He78)ac7aed57f26354e8a484b5d257f7bada$$aBhardwaj, Megha$$b0$$eFirst author$$udkfz
000182535 245__ $$aComparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years.
000182535 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2022
000182535 3367_ $$2DRIVER$$aarticle
000182535 3367_ $$2DataCite$$aOutput Types/Journal article
000182535 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1668178815_5814
000182535 3367_ $$2BibTeX$$aARTICLE
000182535 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182535 3367_ $$00$$2EndNote$$aJournal Article
000182535 500__ $$a#EA:C070#EA:C120#LA:C070#LA:C120#
000182535 520__ $$aRandomized trials have demonstrated considerable reduction in lung cancer (LC) mortality by screening pre-selected heavy smokers with low-dose computed tomography (LDCT). Newer screening guidelines recommend refined LC risk models for selecting the target population for screening. We aimed to evaluate and compare the discrimination performance of LC risk models and previously used trial criteria in predicting LC incidence and mortality in a large German cohort of screening-age adults. Within ESTHER, a population-based prospective cohort study conducted in Saarland, Germany, 4812 ever smokers aged 50-75 years were followed up with respect to LC incidence and mortality for up to 17 years. We quantified the performance of 11 different LC risk models by the area under the curve (AUC) and compared the proportion of correctly predicted LC cases between the best performing models and the LDCT trial criteria. Risk prediction of LC incidence in the ESTHER ever smokers was best for the Bach model, LCRAT and LCDRAT with AUCs ranging from 0.782 to 0.787, from 0.770 to 0.774, and from 0.765 to 0.771 for the follow-up time periods of cases identified at 6, 11, and 17 years, respectively. At cutoffs yielding comparable positivity rates as the LDCT trial criteria, these models would have identified between 11.8 (95% CI 3.0-20.5) and 17.6 (95% CI 10.1-25.2) percent units higher proportions of LC cases occurring during the initial 6 years of follow-up. Use of LC risk models is expected to result in substantially greater potential to identify people at highest risk of LC, suggesting enhanced potential for reducing LC mortality by LC screening.
000182535 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000182535 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000182535 650_7 $$2Other$$aCancer prevention and screening
000182535 650_7 $$2Other$$aLDCT
000182535 650_7 $$2Other$$aLung cancer
000182535 650_7 $$2Other$$aRisk prediction
000182535 650_7 $$2Other$$aSmoking exposure
000182535 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b1$$udkfz
000182535 7001_ $$aHolleczek, Bernd$$b2
000182535 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$eLast author$$udkfz
000182535 773__ $$0PERI:(DE-600)2025812-4$$a10.1016/j.lungcan.2022.10.011$$gVol. 174, p. 83 - 90$$p83 - 90$$tLung cancer$$v174$$x0169-5002$$y2022
000182535 909CO $$ooai:inrepo02.dkfz.de:182535$$pVDB
000182535 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ac7aed57f26354e8a484b5d257f7bada$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000182535 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000182535 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000182535 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000182535 9141_ $$y2022
000182535 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000182535 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000182535 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-11$$wger
000182535 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLUNG CANCER : 2021$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-11
000182535 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bLUNG CANCER : 2021$$d2022-11-11
000182535 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000182535 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000182535 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000182535 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000182535 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000182535 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000182535 9200_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000182535 980__ $$ajournal
000182535 980__ $$aVDB
000182535 980__ $$aI:(DE-He78)C070-20160331
000182535 980__ $$aI:(DE-He78)C120-20160331
000182535 980__ $$aI:(DE-He78)HD01-20160331
000182535 980__ $$aUNRESTRICTED